Affiliation:
1. Cutter Biological, Berkeley, California 94710.
Abstract
The triazole Bay R 3783 was compared with fluconazole, itraconazole, ketoconazole, and amphotericin B in rodent models of superficial and systemic candidiasis, meningocerebral cryptococcosis, and pulmonary aspergillosis. Overall, Bay R 3783 was comparable or slightly superior to fluconazole and markedly superior to itraconazole and ketoconazole in both survival and short-term organ load experiments in models of candidiasis and cryptococcosis but was less effective than amphotericin B. Of the antifungal agents tested, only Bay R 3783 and itraconazole showed any efficacy in the model of pulmonary aspergillosis.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference38 articles.
1. Fluconazole penetration into cerebrospinal fluid: implications for treating fungal infections of the central nervous system;Arndt C. A. S.;J. Infect. Dis.,1988
2. Bifonazole and clotrimazole. Their mode of action and the possible reason for the fungicidal behavior of bifonazole;Berg D.;Arzneim.-Forsch.,1984
3. Itraconazole in the treatment of acute vaginal candidiasis;Bloch B.;S. Afr. Med. J.,1988
4. A clinical trial of itraconazole in the treatment of deep mycoses and leishmaniasis;Borelli D.;Rev. Infect. Dis.,1987
5. Cryptococcal meningitis in the acquired immunodeficiency syndrome (AIDS): successful treatment with fluconazole after failure of amphotericin B;Byrne W. R.;Ann. Intem. Med.,1988
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献